Spina Bifida

Health Care for People with Intellectual and Developmental Disabilities Across the Lifespan

Volumn , Issue , 2016, Pages 847-872

  Jacobs, Robert A ^a   Deavenport Saman, Alexis ^a   Smith, Kathryn ^a   Van Speybroeck, Alex ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978346001     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-18096-0_72     Document Type: Chapter

References (57)

1. Wolraich ML. The needs of children with spina bifida: a comprehensive view. Iowa City: Division Developmental Disabilities, Department Pediatrics, University of Iowa, 1983.
2. Kinsman SL, Levey E, Ruffing V, Stone J, Warren L. Beyond multidisciplinary care: a new conceptual model for spina bifida services. Eur J Pediatr Surg. 2000;10:35-8.
3. Kaufman BA, Terbrock A, Winters N, Ito J, Klosterman A, Park TS. Disbanding a multidisciplinary clinic: effects on the health care of myelomeningocele patients. Pediatr Neurosurg. 1994;21(1):36-44.
4. Blum FW, Garell D, Hodgman CH, Jorissen TW, Okinow NA, Orr DP, Slap GB. Transition from child- centered to adult health care systems for adolescents with chronic conditions. J Adolesc Health. 1993;14:570-6.
5. McComb JG. Spinal and cranial neural tube defects. Semin Pediatr Neurol. 1997;4(3):156-66.
6. Lary JM, Edmonds LD. Prevalence of spina bifida at birth United States, 1983-1990: a comparison of two surveillance systems. MMWR. 1996;39(SS-4):15-26.
7. Centers for Disease Control and Prevention. Data and statistics. www.cdc.gov/ncbddd/birthdefects/data. html. Accessed 2 May 2014.
8. Shin M, Besser LM, Siffel C, et al. Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics. 2010;126:274-9.
9. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabilt Res Rev. 2010;16:6-15.
10. Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. The changing epidemiology of neural tube defects. AJDC. 1992;146:857-61.
11. Carter CO. Clues to the aetiology of neural tube malformations. Dev Med Child Neurol. 1974;16 Suppl 32:3-14.
12. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41(RR-14):1-7.
13. Graf WD, Oleinik OE. The study of neural tube defects after the human genome project and folic acid fortification of foods. Eur J Pediatr Surg. 2000;10 Suppl 1:9-12.
14. Marini NJ, Hoffman TJ, Lammer EJ, et al. A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis. PLoS One. 2011;6:e28408.
15. Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr. 2011;170:1391-400.
16. Imbard A, Benoist JF, Blom HJ. Neural tube defects, folic acid and methylation. Int J Environ Res Public Health. 2013;10:4352-89.
17. Van Allen MI, Kalousek DK, Chernoff GF, Hall JG. Evidence for multisite closure of the neural tube in humans. Am J Med Gen. 1993;47:723-43.
18. McLone DG, Knepper PA. The cause of Chiari II malformation: a unified theory. Pediatr Neurosci. 1989;15:1-12.
19. Platt LD, Feuchtbamm L, Filly R, Lustig L, Simon M, Cunningham GC. The California Maternal Serum Alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida. Am J Obstet Gynecol. 1992;166:1328-9.
20. California AFP Screening Program. AFP update for prenatal care providers. Berkeley: California Department Health Services; 1994.
21. Johnson CY, Honein MA, Dana Flanders W, Howards PP, Oakley GP, Rasmussen SA. Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol. 2012;94:857-63.
22. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA. 1999;282(19):1819-25.
23. Bannister CM. The case for and against intrauterine surgery for myelomeningoceles. Eur J Obstet Gynecol Reprod Biol. 2000;92:109-13.
24. Adzick S, Thorn EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993-1004.
25. Verbeek R, Heep A, Maurits NM, Cremer R, et al. Fetal endoscopic myelomeningoecele closure perseveres segmental neurological function. Dev Med Child Neurol. 2012;54:15-22.
26. Wong LY, Paulozzi LJ. Survival of infants with spina bifida: a population study. Paediatr Perinat Epidemiolol. 2001;15:374-8.
27. Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010;52(8):749-53.
28. Charney EB, Sutton LN, Bruce DA, Schut LB. Myelomeningocele newborn management: time for parental decision. Z Kinderchir. 1983;38 Suppl 2:90-3.
29. Salomao JF, Leibinger RD. Abdominal pseudocysts complicating CSF shunting in infants and children. Pediatr Neurosurg. 1999;31:274-8.
30. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg. 2001;35:66-71.
31. Charney EB, Rorke LB, Sutton LN, Schut L. Management of Chiari II complication in infants with myelomeningocele. J Pediatr. 1987;111(3):364-71.
32. Kirk VG, Morielli A, Brouillette RT. Sleep-disordered breathing in patients with myelomeningocele: the missed diagnosis. Dev Med Child Neurol. 1999;41:40-3.
33. Banta JV. The tethered cord in myelomeningocele: should it be untethered? Dev Med Child Neurol. 1991;33:173-6.
34. Sarwark JF, Weber DT, Gabrieli AP, McLone DG, Dias L. Tethered cord syndrome in low motor level children with myelomeningocele. Pediatr Neurosurg. 1996;25:295-301.
35. Shurtleff DB, Duguay S, Duguay G, Moskowitz D, Weinberger E, Roberts T, Loeser J. Epidemiology of tethered cord with meningomyelocele. Eur J Pediatr Surg. 1997;7 Suppl 1:7-11.
36. LaMarca F, Herman M, Grant JA, McLone DG. Presentation and management of hydromyelia in children with Chiari Type-II malformation. Pediatr Neurosurg. 1997;26:57-67.
37. Stellman-Ward GR, Bannister CM, Lewis MA, Shaw J. The incidence of chronic headache in children with shunted hydrocephalus. Eur J Pediatr Surg. 1997;7 Suppl 1:12-4.
38. Stellman GR, Bannister CM, Hillier V. The incidence of seizure disorder in children with acquired and congenital hydrocephalus. Z Kinderchir. 1986;41(Suppl I):38-41.
39. Leibold S, Ekmark E, Adams RC. Decision-making for a successful bowel continence program. Eur J Pediatr Surg. 2000;10 Suppl 1:26-30.
40. Thomson JD, Segal LS. Orthopedic management of spina bifida. Dev Disabil Res Rev. 2010;16:96-103.
41. McDonald CM, Jaffe KM, Mosca VS, Shurtleff DB. Ambulatory outcome of children with myelomeningocele: effect of lower extremity muscle strength. Dev Med Child Neurol. 1991;33:482-90.
42. Drennan JC. Current concepts in myelomeningocele. AAOS Instr Course Lect. 1999;48:543-50.
43. Dias LS. Hip deformities in myelomeningocele. AAOS Instr Course Lect. 1991;XL:281-6.
44. Banta JV, Drummond DS, Ferguson RL. The treatment of neuromuscular scoliosis. AAOS Instr Course Lect. 1999;48:551-62.
45. Lock TR, Aronson DD. Fractures in patients who have myelomeningocele. J Bone Joint Surg Am. 1989;71(8):1153-7.
46. Raddish M, Goldmann DA, Kaplan LC, Perrin JM. The immunization status of children with spina bifida. AJDC. 1993;147:849-53.
47. Jacobs RA, Blyler E, Baer MT. Nutrition risk factors in children with myelomeningocele. Eur J Pediatr Surg. 1991;1 Suppl 1:22.
48. Bayston R. Hydrocephalus shunt infections. London: Chapman Hall; 1989. p. 139.
49. Caines E, Dahl M, Folke U, Hemmet B. Ophthalmological findings in a prospective study of 22 children with spina bifida cystica. Eur J Pediatr Surg. 1997;7 Suppl 1:52.
50. Kinsman SL, Rawlins C, Finney K, Ruffing V, Speedie L. A conceptual model of higher cortical function impairments in myelomeningocele. Eur J Pediatr Surg. 1998;8 Suppl 1:69-70.
51. Roland M, Jacobs R, Angone E, Fallick B, MacKenzie R. Principles of management of adolescents with spina bifida in the ambulatory setting. Eur J Pediatr Surg. 1997;7 Suppl 1:57-8.
52. Dahl M, Proos LA, Ahlsten G, Tuvermo T, Gustafsson J. Increased intracranial pressure perinatally predicts early puberty in girls with myelomeningocele. Eur J Pediatr Surg. 1996;6 Suppl 1:41-2.
53. Sloan SL, Leibold SR, Henry-Atkinson J, editors. Sexuality and the person with spina bifida. Washington, DC: Spina Bifida Association America; 1994. p. 1-25.
54. Harris MB, Banta JV. Cost of skin care in the myelomeningocele population. J Pediatr Orthop. 1990;10:355-61.
55. Banta JV, Bonanni C, Prebluda J. Latex anaphylaxis during spinal surgery in children with myelomeningocele. Dev Med Child Neurol. 1993;35:540-8.
56. Kwittken PL, Sweinberg SK, Campbell DE, Pawlowski NA. Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics. 1995;95(5):693-9.
57. McLaughlin JF, Shurtleff DB, Lamers JY, Stunts JT, Hayden PW, Kropp RJ. Influence of prognosis on decisions retarding the care of newborns with spina bifida cystica. N Engl J Med. 1985;312:1589-94.